ICU Medical Profit Margin 2006-2019 | ICUI

Current and historical gross margin, operating margin and net profit margin for ICU Medical (ICUI) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. ICU Medical net profit margin as of September 30, 2019 is 5.66%.
ICU Medical Annual Profit Margins
ICU Medical Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.819B $1.400B
ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $149.187B 27.21
Medtronic (MDT) Ireland $148.912B 20.55
Stryker (SYK) United States $75.969B 25.54
Boston Scientific (BSX) United States $59.391B 28.03
Baxter (BAX) United States $41.360B 25.08
Essilor Luxottica (ESLOY) France $32.912B 0.00
Zimmer Biomet Holdings (ZBH) United States $29.495B 18.50
Terumo (TRUMY) Japan $27.172B 33.91
Coloplast (CLPBY) Denmark $25.315B 39.07
Lonza Group Ag (LZAGY) Switzerland $25.204B 0.00
ResMed (RMD) United States $21.492B 39.65
Smith & Nephew SNATS (SNN) United Kingdom $19.178B 0.00
Sunny Optical Technology (SNPTF) China $17.572B 0.00
Insulet (PODD) United States $11.378B 541.29
Bio-Rad Laboratories (BIO) United States $11.123B 53.39
William Demant Holdings (WILYY) Denmark $7.531B 0.00
Hill-Rom Holdings (HRC) United States $7.077B 20.87
Perrigo (PRGO) Ireland $6.765B 12.61
Canopy Growth (CGC) Canada $6.616B 0.00
DiaSorin S.p.A (DSRLF) Italy $6.420B 0.00
Haemonetics (HAE) United States $5.992B 40.49
Shandong Weigao Medical Polymer (SHWGF) China $5.743B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 27.26
NuVasive (NUVA) United States $3.787B 29.82
Neogen (NEOG) United States $3.465B 57.97
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.150B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.132B 0.00
Quidel (QDEL) United States $2.821B 26.77
Aurora Cannabis (ACB) Canada $2.691B 0.00
National Vision Holdings (EYE) United States $2.343B 52.89
Agios Pharmaceuticals (AGIO) United States $2.303B 0.00
Cardiovascular Systems (CSII) United States $1.547B 0.00
InMode (INMD) Israel $1.406B 0.00
Aphria (APHA) $1.192B 0.00
AtriCure (ATRC) United States $1.173B 0.00
VAREX IMAGING (VREX) United States $1.126B 22.55
Phibro Animal Health (PAHC) United States $0.980B 18.35
NanoString Technologies (NSTG) United States $0.937B 0.00
Lantheus Holdings (LNTH) United States $0.791B 19.75
Eagle Pharmaceuticals (EGRX) United States $0.778B 29.79
TG Therapeutics (TGTX) United States $0.778B 0.00
LeMaitre Vascular (LMAT) United States $0.719B 40.43
Omeros (OMER) United States $0.715B 0.00
Quanterix (QTRX) United States $0.707B 0.00
PetIQ (PETQ) United States $0.645B 15.73
Cerus (CERS) United States $0.589B 0.00
Surmodics (SRDX) United States $0.561B 58.56
HEXO (HEXO) $0.555B 0.00
OraSure Technologies (OSUR) United States $0.478B 28.67
MacroGenics (MGNX) United States $0.455B 0.00
Organigram Holdings (OGI) Canada $0.442B 0.00
Owens & Minor (OMI) United States $0.416B 15.40
Utah Medical Products (UTMD) United States $0.392B 28.37
Meridian Bioscience (VIVO) United States $0.391B 13.44
Zynex (ZYXI) United States $0.351B 39.67
BioLife Solutions (BLFS) United States $0.329B 134.08
Neptune Wellness Solutions (NEPT) Canada $0.257B 0.00
United Health Products (UEEC) United States $0.256B 0.00
Bovie Medical (APYX) United States $0.250B 0.00
Viemed Healthcare (VMD) United States $0.230B 24.28
Vapotherm (VAPO) United States $0.225B 0.00
Repro-Med Systems (KRMD) United States $0.192B 0.00
Liberty Health Sciences (LHSIF) Canada $0.171B 0.00
Chimerix (CMRX) United States $0.167B 0.00
InfuSystems Holdings (INFU) United States $0.162B 814.00
Female Health (VERU) United States $0.142B 0.00
Rockwell Medical (RMTI) United States $0.138B 0.00
MTech Acquisition (KERN) United States $0.137B 0.00
Fonar (FONR) United States $0.127B 8.93
Cytosorbents (CTSO) United States $0.126B 0.00
United-Guardian (UG) United States $0.091B 23.08
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
Chembio Diagnostics (CEMI) United States $0.071B 0.00
Nephros (NEPH) United States $0.065B 0.00
MRI Interventions (MRIC) United States $0.059B 0.00
Surface Oncology (SURF) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Trinity Biotech (TRIB) Ireland $0.025B 0.00
Senestech (SNES) United States $0.017B 0.00
GUARDION HEALTH (GHSI) United States $0.015B 0.00
Valeritas Holdings (VLRX) United States $0.013B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Myomo (MYO) United States $0.008B 0.00
Capricor Therapeutics (CAPR) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00
Akers Biosciences Inc (AKER) United States $0.003B 0.00